STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAAR Surgical Company

Staar Surgical Company ($STAA) announced an update on their ongoing clinical study. Staar Surgical’s new proof of concept study, titled “Proof of C...

Staar Surgical Advances Next‑Gen ICL Study, Signaling Long‑Term Growth Potential

Staar Surgical Company ($STAA) announced an update on their ongoing clinical study. The proof of concept study titled “Proof of Concept Study of a ...

Staar Surgical Targets Presbyopia Growth With New Trifocal ICL Trial

The latest announcement is out from Staar Surgical ( ($STAA) ). On August 4, 2026, STAAR Surgical’s board concluded an extensive global search by a...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	STAA	$23.47	-0.45%	1.97M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	STAA	$23.47	-0.4%	1.97M
3
4
5
6

STAA

Get STAAR Surgical Company Data in Excel

Get STAAR Surgical Company Data in Excel